55 COVID-19 projects awarded CSO funding
29th April 2020
Research projects to increase the understanding of coronavirus (COVID-19), screen potential treatments and support clinical trials will benefit from almost £5 million of funding from the Scottish Government's Chief Scientist Office.
The funding will support 55 rapid research projects in 15 Scottish universities and research institutions, contributing to global efforts to combat the virus and its wider effects, including research to:
- better understand the effects of infection
- develop and test new diagnostics and treatments
- investigate new disease surveillance approaches
- inform interventions to prevent transmission of infection
- support the mental health of frontline health and social care workers
- understand the physical and mental health implications of lockdown measures
Health Secretary Jeane Freeman said:
“Scotland is home to some of the most respected researchers and scientists in the world. COVID-19 is the biggest challenge we have faced in our lifetimes and it is vital that we capture the potential of the extraordinarily strong research base here to contribute to the global efforts to tackle and mitigate the impact of it.
“I know many academics are already thinking about how their research can be used during this national and international emergency. This funding enables universities and research institutions to immediately draw on the very best science and methodologies available to build on our understanding of this virus, develop new treatments, stop infection and support people’s mental and physical health.”
Chief Scientist for Health Professor David Crossman said:
“The range of projects – both scientific subject areas and the different research institutions - that are receiving funding will help us understand many aspects of this terrible disease. The projects selected for funding all aim to give results as quickly as possible.
“Scotland is in a strong position to undertake clinical research and the response from universities and research institution to this COVID-19 research call emphatically reinforces that view.”